Ardsley Partners Further Trims Stake in Saba Software, Inc. (SABA)

Philip Hempleman‘s Ardsley Partners reported selling some of its Saba Software, Inc. (OTCMKTS:SABA) holding. The fund disposed a total of 15,000 shares, trimming the position to around 3.31 million shares. The securities have been sold in one deal, the price amounting to $12.36 per share.

Saba Software, Inc. (NASDAQ:SABA)

Overall, in several transactions during the fourth quarter of 2013, Ardsley Partners sold around 61,600 shares of Saba Software, Inc. (OTCMKTS:SABA).

Philip Hempleman’s Ardsley Partners had earlier sold 17,300 shares of Saba Software, Inc. (OTCMKTS:SABA).

In December, Saba Software, Inc. (OTCMKTS:SABA) a global leader in next-generation cloud solutions for talent management, joined Cloud Security Alliance (CSA) a not-for-profit organization that aims provide security assurance within cloud computing. Earlier the company had also announced about its new recruiting offering, Recruiting@Work, to bring objectivity into hiring decisions.

The company managed to add 203 new customers in fiscal 2013 representing a 44% increase over 141 new customers in the fiscal 2012.

Philip Hempleman’s Ardsley Partners initiated a position in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) and bought 1.93 million shares representing 5.7% of the company’s common stock.

Philip Hempleman’s Ardsley Partners, a long/short equity hedge fund, has approximately $1 billion under management. The fund invests in value stocks that are growth oriented and has an inclination towards chemical and chemical-related companies.

Ardsley Partners’ equity portfolio contains Jazz Pharmaceuticals plc (NASDAQ:JAZZ), with 423,500 shares, worth $38.95 million. The second largest holding, in terms of value, is United Rentals, Inc. (NYSE:URI), Ardsley owning 654,300 shares, valued at $38.14 million shares. Another company where the fund has invested a 7.02% of its portfolio is Canadian Solar Inc. (NASDAQ:CSIQ) with 2.03 million shares worth $34.41 million.

Disclosure: none

Recommended Reading:

Blue Mountain Capital Decreases Stake in Lexmark International Inc (LXK)

Pershing Square Increases Stake in Howard Hughes Corp (HHC)

Steven Cohen Opens Position in E-House (China) Holdings Limited (ADR) (EJ)

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!